Indirect Effects of Pneumococcal Conjugate Vaccines in National Immunization Programs for Children on Adult Pneumococcal Disease / 감염과화학요법
Infection and Chemotherapy
; : 257-266, 2016.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-179932
Responsible library:
WPRO
ABSTRACT
The pneumococcal conjugate vaccine (PCV) was developed to overcome the limitations of the pneumococcal polysaccharide vaccine, which produces poor immunogenicity in infants younger than 2 years. As many countries have included PCVs in national immunization programs for children, the incidence of invasive pneumococcal disease caused by vaccine type Streptococcus pneumoniae has declined markedly, not only among the vaccinated pediatric population, but also among unvaccinated adults. In this review, we present a concise overview of the indirect effects of mass pediatric PCV immunization on unvaccinated adults.
Full text:
Available
Health context:
Sustainable Health Agenda for the Americas
/
SDG3 - Health and Well-Being
/
SDG3 - Target 3.3 End transmission of communicable diseases
Health problem:
Goal 10: Communicable diseases
/
Target 3.3: End transmission of communicable diseases
/
Pneumonia
Database:
WPRIM (Western Pacific)
Main subject:
Pneumococcal Infections
/
Streptococcus pneumoniae
/
Mass Vaccination
/
Incidence
/
Immunization
/
Vaccines, Conjugate
/
Immunization Programs
/
Pneumococcal Vaccines
Type of study:
Incidence study
/
Prognostic study
Limits:
Adult
/
Child
/
Humans
/
Infant
Language:
English
Journal:
Infection and Chemotherapy
Year:
2016
Document type:
Article